These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33608889)

  • 1. Emerging role of RNA interference in immune cells engineering and its therapeutic synergism in immunotherapy.
    Monty MA; Islam MA; Nan X; Tan J; Tuhin IJ; Tang X; Miao M; Wu D; Yu L
    Br J Pharmacol; 2021 Apr; 178(8):1741-1755. PubMed ID: 33608889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference and cancer therapy.
    Wang Z; Rao DD; Senzer N; Nemunaitis J
    Pharm Res; 2011 Dec; 28(12):2983-95. PubMed ID: 22009588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.
    Keates AC; Fruehauf J; Xiang S; Li CJ
    Biotechnol Genet Eng Rev; 2008; 25():113-27. PubMed ID: 21412352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade.
    Ganesh S; Shui X; Craig KP; Park J; Wang W; Brown BD; Abrams MT
    Mol Ther; 2018 Nov; 26(11):2567-2579. PubMed ID: 30274786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
    Revia RA; Stephen ZR; Zhang M
    Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral vector-mediated RNA interference.
    Couto LB; High KA
    Curr Opin Pharmacol; 2010 Oct; 10(5):534-42. PubMed ID: 20620113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi and miRNA in viral infections and cancers.
    Mollaie HR; Monavari SH; Arabzadeh SA; Shamsi-Shahrabadi M; Fazlalipour M; Afshar RM
    Asian Pac J Cancer Prev; 2013; 14(12):7045-56. PubMed ID: 24460249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial RNAi: a winning strategy for the race against evolving targets?
    Grimm D; Kay MA
    Mol Ther; 2007 May; 15(5):878-88. PubMed ID: 17311009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference-based therapy and its delivery systems.
    Chen X; Mangala LS; Rodriguez-Aguayo C; Kong X; Lopez-Berestein G; Sood AK
    Cancer Metastasis Rev; 2018 Mar; 37(1):107-124. PubMed ID: 29243000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi in clinical studies.
    Kubowicz P; Żelaszczyk D; Pękala E
    Curr Med Chem; 2013; 20(14):1801-16. PubMed ID: 23432579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo application of RNA interference: from functional genomics to therapeutics.
    Lu PY; Xie F; Woodle MC
    Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference: ready to silence cancer?
    Mocellin S; Costa R; Nitti D
    J Mol Med (Berl); 2006 Jan; 84(1):4-15. PubMed ID: 16283143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.
    Daniels SM; Sinck L; Ward NJ; Melendez-Peña CE; Scarborough RJ; Azar I; Rance E; Daher A; Pang KM; Rossi JJ; Gatignol A
    RNA Biol; 2015; 12(2):123-35. PubMed ID: 25668122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
    Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
    Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [RNA interference: from origins to a novel tool for gene silencing].
    Ortiz-Quintero B
    Rev Invest Clin; 2009; 61(5):412-27. PubMed ID: 20184102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on RNA interference-mediated gene silencing in cancer therapy.
    Ren YJ; Zhang Y
    Expert Opin Biol Ther; 2014 Nov; 14(11):1581-92. PubMed ID: 25010067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in siRNA delivery strategies for the treatment of MDR cancer.
    Subhan MA; Attia SA; Torchilin VP
    Life Sci; 2021 Jun; 274():119337. PubMed ID: 33713664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.